These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36159843)

  • 1. Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium.
    Waerlop G; Leroux-Roels G; Lambe T; Bellamy D; Medaglini D; Pettini E; Cox RJ; Trieu MC; Davies R; Bredholt G; Montomoli E; Gianchecchi E; Clement F
    Front Immunol; 2022; 13():984642. PubMed ID: 36159843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
    Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F
    J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4
    Begue S; Waerlop G; Salaun B; Janssens M; Bellamy D; Cox RJ; Davies R; Gianchecchi E; Medaglini D; Montomoli E; Pettini E; Leroux-Roels G; Clement F; Pagnon A
    Front Immunol; 2022; 13():982887. PubMed ID: 36341380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
    Bernard MC; Waldock J; Commandeur S; Strauß L; Trombetta CM; Marchi S; Zhou F; van de Witte S; van Amsterdam P; Ho S; Hoschler K; Lugovtsev V; Weir JP; Montomoli E; Cox RJ; Engelhardt OG; Friel D; Wagner R; Ollinger T; Germain S; Sediri-Schön H
    Front Immunol; 2022; 13():909297. PubMed ID: 35784305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells.
    Dapporto F; De Tommaso D; Marrocco C; Piu P; Semplici C; Fantoni G; Ferrigno I; Piccini G; Monti M; Vanni F; Razzano I; Manini I; Montomoli E; Manenti A
    J Immunol Methods; 2024 Jan; 524():113588. PubMed ID: 38040193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
    Bestard O; Crespo E; Stein M; Lúcia M; Roelen DL; de Vaal YJ; Hernandez-Fuentes MP; Chatenoud L; Wood KJ; Claas FH; Cruzado JM; Grinyó JM; Volk HD; Reinke P
    Am J Transplant; 2013 Jul; 13(7):1880-90. PubMed ID: 23763435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.
    Patton K; Aslam S; Lin J; Yu L; Lambert S; Dawes G; Esser MT; Woo J; Janetzki S; Cherukuri A
    Clin Vaccine Immunol; 2014 May; 21(5):628-35. PubMed ID: 24574540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S; Spindler T; Kiener R; Tonar C; Lugner T; Batzilla J; Bendfeldt H; Rascle A; Asbach B; Wagner R; Deml L
    BMC Immunol; 2017 Mar; 18(1):14. PubMed ID: 28270111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
    Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
    mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets.
    Pillet S; Kobasa D; Meunier I; Gray M; Laddy D; Weiner DB; von Messling V; Kobinger GP
    Vaccine; 2011 Sep; 29(39):6793-801. PubMed ID: 21211587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic Cell-Based ELISpot Assay for Assessing T-Cell IFN-γ Responses in Human Peripheral Blood Mononuclear Cells to Dengue Envelope Proteins.
    Sun P; Simmons M
    Methods Mol Biol; 2018; 1808():187-196. PubMed ID: 29956185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay.
    Sedegah M
    Methods Mol Biol; 2015; 1325():197-205. PubMed ID: 26450390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel IFN-γ ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
    Yung BS; Pugh H; Generotti AA; Phanhthilath N; Schultheis K; Muthumani K; Broderick KE; Smith TRF
    Vaccine; 2019 Feb; 37(7):903-909. PubMed ID: 30661837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISpot Assay for the Detection of ASFV-Specific Interferon-Gamma (IFN-γ)-Producing Cells.
    Portugal R
    Methods Mol Biol; 2022; 2503():169-178. PubMed ID: 35575894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
    Samri A; Durier C; Urrutia A; Sanchez I; Gahery-Segard H; Imbart S; Sinet M; Tartour E; Aboulker JP; Autran B; Venet A;
    Clin Vaccine Immunol; 2006 Jun; 13(6):684-97. PubMed ID: 16760328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.
    Forrest BD; Pride MW; Dunning AJ; Capeding MR; Chotpitayasunondh T; Tam JS; Rappaport R; Eldridge JH; Gruber WC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1042-53. PubMed ID: 18448618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISpot for measuring human immune responses to vaccines.
    Slota M; Lim JB; Dang Y; Disis ML
    Expert Rev Vaccines; 2011 Mar; 10(3):299-306. PubMed ID: 21434798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
    Boaz MJ; Hayes P; Tarragona T; Seamons L; Cooper A; Birungi J; Kitandwe P; Semaganda A; Kaleebu P; Stevens G; Anzala O; Farah B; Ogola S; Indangasi J; Mhlanga P; Van Eeden M; Thakar M; Pujari A; Mishra S; Goonetilleke N; Moore S; Mahmoud A; Sathyamoorthy P; Mahalingam J; Narayanan PR; Ramanathan VD; Cox JH; Dally L; Gill DK; Gilmour J
    Clin Vaccine Immunol; 2009 Feb; 16(2):147-55. PubMed ID: 19091991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method.
    Mak WA; Koeleman JGM; Ong DSY
    J Virol Methods; 2022 Feb; 300():114398. PubMed ID: 34863782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting induction of peripheral IFN-γ recall response to influenza A virus vaccination in pigs.
    Olson ZF; Sandbulte MR; Souza CK; Perez DR; Vincent AL; Loving CL
    Vet Immunol Immunopathol; 2017 Mar; 185():57-65. PubMed ID: 28242003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.